Co-Authors
This is a "connection" page, showing publications co-authored by George Hofmeyr and Jennifer Smit.
Connection Strength
0,898
-
Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLoS One. 2024; 19(5):e0299802.
Score: 0,238
-
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
Score: 0,236
-
Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial. EClinicalMedicine. 2021 Apr; 34:100800.
Score: 0,192
-
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
Score: 0,061
-
True and false positive HIV point of care test results in a prospective multinational study of at-risk African women: implications for large-scale repeat HIV testing in HIV prevention programs. J Acquir Immune Defic Syndr. 2024 Aug 01.
Score: 0,061
-
Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. PLoS One. 2023; 18(12):e0295959.
Score: 0,058
-
High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):130-137.
Score: 0,052